The global clinical literature improvement market is expected to grow at a CAGR of 7.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing number of healthcare providers and payers that are adopting clinical documentation improvement solutions for improving their operational efficiency and reducing costs.
Clinical Documentation Improvement Solutions: The global clinical documentation improvement market is expected to grow at a CAGR of 8.2% during the forecast period, from 2021 to 2030. This growth can be attributed to the increasing adoption of electronic health records (EHRs) by healthcare providers and payers for improving their operational efficiency and reducing costs.
Clinical Coding Improvement Solutions: The global clinical coding improvement market is expected to grow at a CAGR of 6% during the forecast period, from 2021 to 2030. This growth can be attributed primarily due to increased adoption by healthcare providers and payers for improving their operational efficiency and reducing costs as well as due to increased demand for accurate coding in order meet regulatory requirements such as ICD-10-CM/PCS or HIPAA compliance standards in various countries across North America, Europe, Asia Pacific, Latin America, Middle East & Africa regions.
Some Of The Growth Factors Of This Market:
- The clinical literature improvement market is driven by the need for better quality and more efficient research.
- Clinical trials are becoming increasingly expensive, which has led to an increase in the number of studies that are being conducted outside of the US and Europe.
- There is a growing need for improved data management systems in order to improve efficiency and reduce costs.
- The clinical literature improvement market will be driven by an increased focus on patient safety.
Industry Growth Insights published a new data on “Clinical Literature Improvement Market”. The research report is titled “Clinical Literature Improvement Market research by Types (Clinical Documentation, Clinical Coding, Charge Capture Solutions, Pre-Bill Review, Diagnosis-Related Grouping, Other, Clinical Literature Improvemen), By Applications (Healthcare Providers, Healthcare Payers), By Players/Companies 3M Company, Optum, Nuance, M*Modal, NThrive, Dolbey Systems, Streamline Health, Vitalware, Craneware, Epic Systems, Cerner, Iodine Software, Flash Code, Clinical Literature Improvemen”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Clinical Literature Improvement Market Research Report
By Type
Clinical Documentation, Clinical Coding, Charge Capture Solutions, Pre-Bill Review, Diagnosis-Related Grouping, Other, Clinical Literature Improvemen
By Application
Healthcare Providers, Healthcare Payers
By Companies
3M Company, Optum, Nuance, M*Modal, NThrive, Dolbey Systems, Streamline Health, Vitalware, Craneware, Epic Systems, Cerner, Iodine Software, Flash Code, Clinical Literature Improvemen
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
246
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Clinical Literature Improvement Market Report Segments:
The global Clinical Literature Improvement market is segmented on the basis of:
Types
Clinical Documentation, Clinical Coding, Charge Capture Solutions, Pre-Bill Review, Diagnosis-Related Grouping, Other, Clinical Literature Improvemen
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Healthcare Providers, Healthcare Payers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- 3M Company
- Optum
- Nuance
- M*Modal
- NThrive
- Dolbey Systems
- Streamline Health
- Vitalware
- Craneware
- Epic Systems
- Cerner
- Iodine Software
- Flash Code
- Clinical Literature Improvemen
Highlights of The Clinical Literature Improvement Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Clinical Documentation
- Clinical Coding
- Charge Capture Solutions
- Pre-Bill Review
- Diagnosis-Related Grouping
- Other
- Clinical Literature Improvemen
- By Application:
- Healthcare Providers
- Healthcare Payers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Clinical Literature Improvement Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Clinical literature improvement is a process of systematically improving the quality and accuracy of clinical research papers.
Some of the major players in the clinical literature improvement market are 3M Company, Optum, Nuance, M*Modal, NThrive, Dolbey Systems, Streamline Health, Vitalware, Craneware, Epic Systems, Cerner, Iodine Software, Flash Code, Clinical Literature Improvemen.
The clinical literature improvement market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Clinical Literature Improvement Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Clinical Literature Improvement Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Clinical Literature Improvement Market - Supply Chain
4.5. Global Clinical Literature Improvement Market Forecast
4.5.1. Clinical Literature Improvement Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Clinical Literature Improvement Market Size (000 Units) and Y-o-Y Growth
4.5.3. Clinical Literature Improvement Market Absolute $ Opportunity
5. Global Clinical Literature Improvement Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Clinical Literature Improvement Market Size and Volume Forecast by Type
5.3.1. Clinical Documentation
5.3.2. Clinical Coding
5.3.3. Charge Capture Solutions
5.3.4. Pre-Bill Review
5.3.5. Diagnosis-Related Grouping
5.3.6. Other
5.3.7. Clinical Literature Improvemen
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Clinical Literature Improvement Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Clinical Literature Improvement Market Size and Volume Forecast by Application
6.3.1. Healthcare Providers
6.3.2. Healthcare Payers
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Clinical Literature Improvement Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Clinical Literature Improvement Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Clinical Literature Improvement Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Clinical Literature Improvement Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Clinical Literature Improvement Demand Share Forecast, 2019-2026
9. North America Clinical Literature Improvement Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Clinical Literature Improvement Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Clinical Literature Improvement Market Size and Volume Forecast by Application
9.4.1. Healthcare Providers
9.4.2. Healthcare Payers
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Clinical Literature Improvement Market Size and Volume Forecast by Type
9.7.1. Clinical Documentation
9.7.2. Clinical Coding
9.7.3. Charge Capture Solutions
9.7.4. Pre-Bill Review
9.7.5. Diagnosis-Related Grouping
9.7.6. Other
9.7.7. Clinical Literature Improvemen
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Clinical Literature Improvement Demand Share Forecast, 2019-2026
10. Latin America Clinical Literature Improvement Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Clinical Literature Improvement Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Clinical Literature Improvement Market Size and Volume Forecast by Application
10.4.1. Healthcare Providers
10.4.2. Healthcare Payers
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Clinical Literature Improvement Market Size and Volume Forecast by Type
10.7.1. Clinical Documentation
10.7.2. Clinical Coding
10.7.3. Charge Capture Solutions
10.7.4. Pre-Bill Review
10.7.5. Diagnosis-Related Grouping
10.7.6. Other
10.7.7. Clinical Literature Improvemen
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Clinical Literature Improvement Demand Share Forecast, 2019-2026
11. Europe Clinical Literature Improvement Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Clinical Literature Improvement Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Clinical Literature Improvement Market Size and Volume Forecast by Application
11.4.1. Healthcare Providers
11.4.2. Healthcare Payers
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Clinical Literature Improvement Market Size and Volume Forecast by Type
11.7.1. Clinical Documentation
11.7.2. Clinical Coding
11.7.3. Charge apture Solutions
11.7.4. Pre-Bill Review
11.7.5. Diagnosis-Related Grouping
11.7.6. Other
11.7.7. Clinical Literature Improvemen
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Clinical Literature Improvement Demand Share, 2019-2026
12. Asia Pacific Clinical Literature Improvement Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Clinical Literature Improvement Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Clinical Literature Improvement Market Size and Volume Forecast by Application
12.4.1. Healthcare Providers
12.4.2. Healthcare Payers
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Clinical Literature Improvement Market Size and Volume Forecast by Type
12.7.1. Clinical Documentation
12.7.2. Clinical Coding
12.7.3. Charge Capture Solutions
12.7.4. Pre-Bill Review
12.7.5. Diagnosis-Related Grouping
12.7.6. Other
12.7.7. Clinical Literature Improvemen
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Clinical Literature Improvement Demand Share, 2019-2026
13. Middle East & Africa Clinical Literature Improvement Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Clinical Literature Improvement Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Clinical Literature Improvement Market Size and Volume Forecast by Application
13.4.1. Healthcare Providers
13.4.2. Healthcare Payers
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Clinical Literature Improvement Market Size and Volume Forecast by Type
13.7.1. Clinical Documentation
13.7.2. Clinical Coding
13.7.3. Charge Capture Solutions
13.7.4. Pre-Bill Review
13.7.5. Diagnosis-Related Grouping
13.7.6. Other
13.7.7. Clinical Literature Improvemen
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Clinical Literature Improvement Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Clinical Literature Improvement Market: Market Share Analysis
14.2. Clinical Literature Improvement Distributors and Customers
14.3. Clinical Literature Improvement Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. 3M Company
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Optum
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Nuance
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. M*Modal
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. NThrive
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Dolbey Systems
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Streamline Health
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Vitalware
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Craneware
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Epic Systems
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Cerner
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Iodine Software
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Flash Code
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Clinical Literature Improvemen
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
